Jane Street Group, LLC Argenx Se Transaction History

Jane Street Group, LLC

$444 Billion
Q4 2024

A detailed history of Jane Street Group, LLC transactions in Argenx Se stock. As of the latest transaction made, Jane Street Group, LLC holds 27,875 shares of ARGX stock, worth $18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,875

Previous 8,810 216.4%

Holding current value

$18 Million

Previous $4.78 Million 258.79%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$520.52 - $638.33 $9.92 Million - $12.2 Million	19,065 Added 216.4%	27,875 $17.1 Million
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $4.56 Million - $5.79 Million	-10,496 Reduced 54.37%	8,810 $4.78 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $18,868 - $23,932	-53 Reduced 0.27%	19,306 $8.3 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $2.33 Million - $2.7 Million	-6,535 Reduced 25.24%	19,359 $7.62 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $4.84 Million - $7.22 Million	14,268 Added 122.72%	25,894 $9.85 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $6,648 - $9,871	18 Added 0.16%	11,626 $5.72 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $3.51 Million - $4.11 Million	9,737 Added 520.42%	11,608 $4.52 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $1.64 Million - $1.99 Million	-4,921 Reduced 72.45%	1,871 $697,000
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $11 Million - $12.9 Million	-32,176 Reduced 82.57%	6,792 $2.57 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $13.4 Million - $15.4 Million	38,968 New	38,968 $13.8 Million
Q4 2021 Feb 15, 2022	SELL	$272.01 - $353.03 $10.6 Million - $13.8 Million	-38,974 Reduced 73.43%	14,101 $4.94 Million
Q3 2021 Nov 16, 2021	BUY	$295.0 - $350.58 $10.6 Million - $12.6 Million	35,800 Added 207.24%	53,075 $16 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $11.4 Million - $14.2 Million	-44,296 Reduced 71.94%	17,275 $5.2 Million
Q4 2020 Feb 17, 2021	BUY	$248.13 - $308.36 $10.4 Million - $13 Million	42,018 Added 214.89%	61,571 $18.1 Million
Q3 2020 Nov 17, 2020	SELL	$215.51 - $272.51 $1.6 Million - $2.03 Million	-7,432 Reduced 27.54%	19,553 $5.13 Million
Q2 2020 Aug 17, 2020	BUY	$127.44 - $232.72 $2 Million - $3.66 Million	15,726 Added 139.67%	26,985 $6.08 Million
Q1 2020 May 15, 2020	SELL	$108.83 - $165.23 $13.3 Million - $20.1 Million	-121,845 Reduced 91.54%	11,259 $1.48 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $14.2 Million - $21.9 Million	133,104 New	133,104 $21.4 Million
Q1 2019 May 16, 2019	SELL	$98.85 - $134.59 $1.4 Million - $1.91 Million	-14,155 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$63.81 - $109.82 $5.18 Million - $8.91 Million	-81,143 Reduced 85.15%	14,155 $1.36 Million
Q3 2018 Nov 14, 2018	BUY	$75.5 - $96.63 $6.61 Million - $8.47 Million	87,614 Added 1140.21%	95,298 $7.23 Million
Q2 2018 Aug 15, 2018	SELL	$74.84 - $100.16 $823 - $1,101	-11 Reduced 0.14%	7,684 $637,000
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $438,230 - $655,537	7,695 New	7,695 $619,000

Others Institutions Holding ARGX

# of Institutions

432

Shares Held

29.2M

Call Options Held

390K

Put Options Held

272K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.7B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Argenx Se Transaction History